Erratum to: Dual HER2 blockade: preclinical and clinical data

por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado 2014

Dual HER2 blockade: preclinical and clinical data

por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado 2014

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

por Tanei, Tomonori, Choi, Dong Soon, Rodriguez, Angel A., Liang, Diana Hwang, Dobrolecki, Lacey, Ghosh, Madhumita, Landis, Melissa D., Chang, Jenny C.
Publicado 2016

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

por Granados-Principal, Sergio, Liu, Yi, Guevara, Maria L, Blanco, Elvin, Choi, Dong Soon, Qian, Wei, Patel, Tejal, Rodriguez, Angel A, Cusimano, Joseph, Weiss, Heidi L, Zhao, Hong, Landis, Melissa D, Dave, Bhuvanesh, Gross, Steven S, Chang, Jenny C
Publicado 2015

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells

por Debeb, Bisrat G, Zhang, Xiaomei, Krishnamurthy, Savitri, Gao, Hui, Cohen, Evan, Li, Li, Rodriguez, Angel A, Landis, Melissa D, Lucci, Anthony, Ueno, Naoto T, Robertson, Fredika, Xu, Wei, Lacerda, Lara, Buchholz, Thomas A, Cristofanilli, Massimo, Reuben, James M, Lewis, Michael T, Woodward, Wendy A
Publicado 2010

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea...

por Patel, Tejal A., Ensor, Joe E., Creamer, Sarah L., Boone, Toniva, Rodriguez, Angel A., Niravath, Poly A., Darcourt, Jorge G., Meisel, Jane L., Li, Xiaoxian, Zhao, Jing, Kuhn, John G., Rosato, Roberto R., Qian, Wei, Belcheva, Anna, Schwartz, Mary R., Kaklamani, Virginia G., Chang, Jenny C.
Publicado 2019